We are live on ! Find out more
AI

AdvisorShares Investments Portfolio holdings

AUM $549M
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
+1.35%
1 Year Est. Return
+32.58%
3 Year Est. Return
+93.4%
5 Year Est. Return
+34.9%
10 Year Est. Return
AUM
$321M
AUM Growth
-$34.5M
Cap. Flow
-$30.3M
Cap. Flow %
-9.45%
Top 10 Hldgs %
62.18%
Holding
356
New
50
Increased
96
Reduced
117
Closed
77

Sector Composition

Rank Sector Weight
1 Healthcare 8.13%
2 Consumer Discretionary 7.04%
3 Industrials 5.93%
4 Technology 4.38%
5 Financials 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDCE
151
DELISTED
PDC Energy, Inc.
PDCE
$357K 0.11%
5,558
-12,544
-69% -$812K
LPX icon
152
Louisiana-Pacific
LPX
$5.2B
$357K 0.11%
6,578
-72
-1% -$4.41K
CF icon
153
CF Industries
CF
$18.4B
$354K 0.11%
4,890
+1,146
+31% +$93.7K
ARCH
154
DELISTED
Arch Resources, Inc.
ARCH
$353K 0.11%
2,687
-30
-1% -$4.34K
OXY icon
155
Occidental Petroleum
OXY
$58.6B
$352K 0.11%
5,646
-13,316
-70% -$827K
SYF icon
156
Synchrony
SYF
$25.4B
$351K 0.11%
12,058
-133
-1% -$4.47K
NXST icon
157
Nexstar Media Group
NXST
$5.91B
$350K 0.11%
2,026
-22
-1% -$4.05K
OVV icon
158
Ovintiv
OVV
$17.6B
$346K 0.11%
9,598
-14,920
-61% -$658K
COP icon
159
ConocoPhillips
COP
$148B
$335K 0.1%
3,381
-37
-1% -$4.05K
MED icon
160
Medifast
MED
$135M
$332K 0.1%
3,205
-35
-1% -$3.88K
MOS icon
161
The Mosaic Company
MOS
$7.46B
$328K 0.1%
7,157
-79
-1% -$3.83K
TAP icon
162
Molson Coors Class B
TAP
$7.93B
$301K 0.09%
5,830
+2,000
+52% +$104K
DFTX
163
Definium Therapeutics
DFTX
$5.99B
$296K 0.09%
93,310
-20,127
-18% -$66.9K
NAPA
164
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$291K 0.09%
18,328
+6,000
+49% +$94.4K
ATAI icon
165
AtaiBeckley Inc
ATAI
$2.68B
$290K 0.09%
160,337
-47,694
-23% -$80.8K
ALKS icon
166
Alkermes
ALKS
$8.29B
$285K 0.09%
10,099
-602
-6% -$16.4K
SEEL
167
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$276K 0.09%
104
+7
+7% +$20.5K
SAGE
168
DELISTED
Sage Therapeutics
SAGE
$262K 0.08%
6,250
-889
-12% -$38.2K
ITCI
169
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$262K 0.08%
4,830
-399
-8% -$19.3K
BKNG icon
170
Booking.com
BKNG
$160B
$244K 0.08%
+2,300
New +$224K
ENVB icon
171
Enveric Biosciences
ENVB
$6.2M
$240K 0.08%
795
+149
+23% +$62.7K
REUN
172
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$236K 0.07%
342,529
+212,288
+163% +$237K
RLMD icon
173
Relmada Therapeutics
RLMD
$484M
$235K 0.07%
104,140
+22,778
+28% +$78.5K
ARCO icon
174
Arcos Dorados Holdings
ARCO
$1.7B
$222K 0.07%
28,848
-4,000
-12% -$32.9K
PLYA
175
DELISTED
Playa Hotels & Resorts
PLYA
$222K 0.07%
23,101
+4,766
+26% +$38K

Similar funds

AdvisorShares Investments's Q1 2023 Portfolio in Review

As of Q1 2023, AdvisorShares Investments held 356 positions worth $321M, down 9.7% from $355M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

AdvisorShares Investments withdrew a net $30.3M in Q1 2023, closing 77 positions and reducing 117 holdings. Its most notable exit was Invesco S&P 500 Low Volatility ETF, an estimated $39.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 8.1% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, AdvisorShares Investments opened a new position in State Street SPDR S&P 500 ETF Trust worth $41.2M.

  • AdvisorShares Investments's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 100,694 shares worth $41.2M.
  • AdvisorShares Investments added most to AdvisorShares Pure US Cannabis ETF in Q1 2023, an estimated $6.72M increase.
  • AdvisorShares Investments's biggest Q1 2023 reduction was Jazz Pharmaceuticals, cutting an estimated $6.73M.
  • AdvisorShares Investments fully exited Invesco S&P 500 Low Volatility ETF in Q1 2023, selling an estimated $39.6M.
  • AdvisorShares Investments's ten largest holdings make up 62% of its $321M portfolio in Q1 2023.
  • AdvisorShares Investments opened 50 new positions and closed 77 in Q1 2023.
  • AdvisorShares Investments's portfolio value fell 9.7% quarter-over-quarter to $321M.

Based on AdvisorShares Investments's 13F filing for Q1 2023, filed 9 May 2023.